Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

ClinicalTrials.gov ID: NCT05156281

Public ClinicalTrials.gov record NCT05156281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Study identification

NCT ID
NCT05156281
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,007 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 13, 2021 (Actual)
Primary completion
Jul 22, 2026 (Actual)
Completion
Oct 30, 2030 (Estimated)
Last update posted
Aug 18, 2026

2021 – 2030

United States locations

U.S. sites
50
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
Ctr for Neurology and Spine Phoenix Arizona 85018 —
Vladimir Royter MD APMC Hanford California 93230 —
VA Greater LA Healthcare System Los Angeles California 90073 —
Regina Berkovich MD PhD Inc West Hollywood California 90048 —
CU Anschutz Med Campus Aurora Colorado 80045 —
Colorado Neurological Research PC Denver Colorado 80210 —
New England Institute for Clinical Research Stamford Connecticut 06905 —
Georgetown University Hospital Research Washington D.C. District of Columbia 20007 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Nova Clinical Research LLC Bradenton Florida 34209 —
University of Florida Gainesville Florida 32610 —
Memorial Healthcare System Hollywood Florida 33021 —
Neurology Associates PA Maitland Florida 32751 —
Gables Neurology Miami Florida 33133 —
UM Department Of Neurology Miami Florida 33136 —
Aqualane Clinical Research Naples Florida 34105 —
Advent Health Orlando Orlando Florida 32803 —
Humanity Clinical Research Pembroke Pines Florida 33024 —
Emerald Coast Neurology Pensacola Florida 32514 —
Brain and Spine Institute Port Orange Florida 32127 —
Vero Beach Neurology Vero Beach Florida 32960 —
Conquest Research Winter Park Florida 32789 —
Methodist Neuroscience Institute Merrillville Indiana 46410 —
University of Kansas Hospital Kansas City Kansas 66160 —
Baptist Physicians Lexington Nicholasville Kentucky 40356 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Clinre Comprehensive Neurology Frederick Maryland 21702 —
Tufts Medical Center Boston Massachusetts 02111 —
Kansas City VA Medical Center Kansas City Missouri 64128 —
South Shore Neurologic Associates Patchogue New York 11772 —
University Of NC At Chapel Hill Chapel Hill North Carolina 27599 9500 —
Piedmont HealthCare Charlotte North Carolina 28210 —
The Boster Ctr for MS Columbus Ohio 43235 —
Neurology Diagnostics Inc Dayton Ohio 45408 —
Penn State Hershey Medical Center Hershey Pennsylvania 17033 —
Premier Neurology Greenville South Carolina 29605 —
Metrolina Neurological Associates PA Old Point Station South Carolina 29707 —
Sibyl Wray MD Neurology PC Knoxville Tennessee 37922 —
Neurology Consultants Of Dallas PA Dallas Texas 75231 —
Med Research Inc El Paso Texas 79935 —
Lone Star Neurology Frisco Texas 75035 —
UT Health MARC Medical Arts and Research Center San Antonio Texas 78229 —
Lonestar Neurology of San Antonio San Antonio Texas 78258 —
Texas Institute for Neurological Disorders Sherman Texas 75092 —
Baylor Scott and White Temple Texas 76508 —
Virginia Mason Medical Centre Seattle Washington 98101 —
University of Washington MS Clinic Seattle Washington 98133 —
Elligo Health Research Crab Orchard West Virginia 25827 —
Ascension St Francis Center Milwaukee Wisconsin 53215 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 173 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05156281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05156281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →